Thomas L Jang Selected Research

Thomas L Jang Research Topics

22	Prostatic Neoplasms (Prostate Cancer) 07/2023 - 09/2005
16	Neoplasms (Cancer) 01/2023 - 03/2005
5	Renal Cell Carcinoma (Grawitz Tumor) 12/2020 - 01/2009
4	Urinary Bladder Neoplasms (Bladder Cancer) 11/2023 - 01/2018
3	Neoplasm Metastasis (Metastasis) 07/2023 - 02/2006
3	Testicular Neoplasms (Testicular Cancer) 01/2022 - 03/2019
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 10/2021 - 01/2020
2	Disease Progression 07/2008 - 11/2007
2	Necrosis 08/2006 - 03/2005
1	Melanoma (Melanoma, Malignant) 01/2023
1	Penile Neoplasms (Penile Cancer) 01/2023
1	Rhabdomyosarcoma 01/2023
1	Vulvar Neoplasms (Vulvar Cancer) 01/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Venous Thromboembolism 10/2022
1	Nonseminomatous germ cell tumor 01/2022
1	Teratoma (Teratoid Tumor) 10/2021
1	Seminoma 01/2020
1	Flatulence 03/2019
1	Urethral Obstruction 04/2010
1	Chronic Renal Insufficiency 01/2009
1	Hypertension (High Blood Pressure) 10/2008
1	Kidney Neoplasms (Kidney Cancer) 07/2008
1	Infections 02/2006
1	Urethral Stricture 01/2006
1	Fistula 01/2006
1	Margins of Excision 03/2005
1	Prostatitis 06/2003
1	Inflammation (Inflammations) 06/2003

5	AndrogensIBA 07/2023 - 08/2006
3	Transforming Growth Factor beta (TGF-beta)IBA 05/2009 - 09/2005
2	Prostate-Specific Antigen (Semenogelase)IBA 06/2022 - 12/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2006 - 02/2006
2	CytokinesIBA 02/2006 - 06/2003
1	Kazal Pancreatic Trypsin InhibitorIBA 01/2023
1	Tumor Biomarkers (Tumor Markers)IBA 01/2023
1	Androgen Antagonists (Antiandrogens)IBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	MicroRNAs (MicroRNA)IBA 10/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	alvimopan FDA Link 03/2019
1	Immune Checkpoint InhibitorsIBA 01/2017
1	MethyltransferasesIBA 01/2011
1	DNA (Deoxyribonucleic Acid)IBA 01/2011
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 05/2009
1	Keratin-18 (Keratin 18)IBA 05/2009
1	VimentinIBA 05/2009
1	NF-kappa B (NF-kB)IBA 05/2009
1	ClusterinIBA 08/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2006
1	PerforinIBA 02/2006
1	Interleukin-2 (IL2)IBA 02/2006
1	Transforming Growth Factor-beta Type II ReceptorIBA 02/2006
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 09/2005
1	CholesterolIBA 03/2005
1	ChemokinesIBA 06/2003
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2003
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 06/2003

11	Therapeutics 07/2023 - 11/2007
9	Lymph Node Excision (Lymph Node Dissection) 11/2023 - 01/2019
8	Prostatectomy (Retropubic Prostatectomy) 01/2022 - 02/2006
7	Nephrectomy 10/2022 - 07/2008
5	Cystectomy 11/2023 - 01/2018
5	Radiotherapy 06/2021 - 12/2007
3	Drug Therapy (Chemotherapy) 01/2023 - 01/2020
2	Aftercare (After-Treatment) 10/2021 - 01/2011
2	Length of Stay 03/2019 - 04/2010
2	Adjuvant Radiotherapy 01/2019 - 10/2018
1	Castration 07/2023
1	Operative Time 01/2023
1	Enhanced Recovery After Surgery 01/2023
1	Hysterectomy 01/2023
1	Salpingectomy 01/2023
1	Adjuvant Chemotherapy 11/2022
1	Minimally Invasive Surgical Procedures 12/2020
1	Combined Modality Therapy 01/2019
1	Urinary Diversion (Ileal Conduit) 01/2018
1	Neoadjuvant Therapy 01/2017
1	Free Tissue Flaps 01/2006
1	Cryosurgery 03/2005